Article Details

Ridgeback Biotherapeutics LP Announces the Approval of EbangaTM for Ebola

Retrieved on: 2020-12-22 15:11:15

Tags for this article:

Click the tags to see associated articles and topics

Ridgeback Biotherapeutics LP Announces the Approval of EbangaTM for Ebola. View article details on hiswai:

Excerpt

Ridgeback Biotherapeutics LP (“Ridgeback”), a biotechnology company experienced in antiviral drug development, announced today that the U.S. ...

Article found on: www.valdostadailytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up